Fig. 6From: A pan-cancer analysis indicates long noncoding RNA HAND2-AS1 as a potential prognostic, immunomodulatory and therapeutic biomarker in various cancers including colorectal adenocarcinomaHAND2-AS1 expression levels exhibit variability across distinct cancer types. A Illustrates HAND2-AS1 level profiles between tumors and normal tissues, focusing on significant cancers. B Depicts the expression levels of HAND2-AS1 in diverse CRC cell lines. *p < 0.05Back to article page